Tue, January 18, 2022

Matthew Harrison Maintained (BGNE) at Buy with Decreased Target to $360 on, Jan 18th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-360-on-jan-18th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Matthew Harrison of Morgan Stanley, Maintained "BeiGene, Ltd." (BGNE) at Buy with Decreased Target from $407 to $360 on, Jan 18th, 2022.

Matthew has made no other calls on BGNE in the last 4 months.



There are 2 other peers that have a rating on BGNE. Out of the 2 peers that are also analyzing BGNE, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Andrew Berens of "SVB Leerink" Maintained at Buy with Decreased Target to $414 on, Thursday, October 14th, 2021
  • Rebecca Liang of "Bernstein" Initiated at Buy and Held Target at $431 on, Tuesday, October 12th, 2021